Literature DB >> 20164104

Smoking cessation program in outpatient clinics of Family Medicine Department in Taiwan: a longitudinal evaluation.

Kuang-Chieh Hsueh1, Chih-Yin Chen, Yi-Hsin Yang, Chih-Ling Huang.   

Abstract

The Government of Taiwan has imposed a tobacco health tax of NT$5 (US$0.14) per pack of cigarettes since January 2002. The Department of Health has now begun to fund a smoking cessation program that provides nicotine-replacement therapy (NRT) and brief counseling by physicians in outpatient clinics. The purpose of the current study was to evaluate the smoking cessation program with a 3-year follow-up review implemented at outpatient clinics, which were run by the Family Medicine Department in a medical center, with a total of 772 adult participants. The abstinence rates were 99.7%, 49.2%, 37.7%, 30.2%, and 22.7%, at the 1-, 3-, 6-, 12-, and 36-month points, respectively. The frequency of clinic visits is a major factor predicting long-term cessation. The results indicate the need to pursue implementation and evaluation of multidisciplinary interventions in smoking cessation clinics with a longer follow-up, including the promotion of compliance to increase clinic visits and prevent relapse.

Entities:  

Mesh:

Year:  2010        PMID: 20164104     DOI: 10.1177/0163278709356185

Source DB:  PubMed          Journal:  Eval Health Prof        ISSN: 0163-2787            Impact factor:   2.651


  9 in total

1.  Nicotine gum or patch treatment for smoking cessation and smoking reduction: a multi-centre study in Chinese physicians.

Authors:  Dan Xiao; Nanshan Zhong; Chunxue Bai; Qingyu Xiu; Canmao Xie; Dayi Hu; Yun Mao; Roland Perfekt; Elisabeth Kruse; Qing Li; John Jiangnan Liu; Chen Wang
Journal:  Front Med       Date:  2014-01-23       Impact factor: 4.592

2.  Nicotine dependence treatment: provision of a dedicated programme by the National Addictions Management Service.

Authors:  Lambert Tchern Kuang Low; Charis Wei Ling Ng; Cheng Lee
Journal:  Singapore Med J       Date:  2019-06-14       Impact factor: 1.858

3.  An Effective Strategy to Activate Physicians to Promote High Cardiovascular Risk Patients to Quit Smoking.

Authors:  Cheng-Huang Su; Jiann-Shing Jeng; Shih-Te Tu; Chien-Ning Huang; Hung-I Yeh
Journal:  Acta Cardiol Sin       Date:  2022-07       Impact factor: 1.800

4.  The effect of a very brief smoking-reduction intervention in smokers who have no intention to quit: study protocol for a randomized controlled trial.

Authors:  Lei Wu; Yao He; Bin Jiang; Di Zhang; Hui Tian; Fang Zuo; Tai Hing Lam; Yee Tak Derek Cheung
Journal:  BMC Public Health       Date:  2015-04-25       Impact factor: 3.295

5.  Comparisons of early and delayed abstainers and its effects on long-term smoking cessation in Taiwan.

Authors:  Yu-Chen Chang; Wei-Hsin Huang; Chia-Ying Tsai; Lee-Ching Hwang
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-08-14

6.  The relationship between smoking status and health-related quality of life among smokers who participated in a 1-year smoking cessation programme in Taiwan: a cohort study using the EQ-5D.

Authors:  Pei-Ching Chen; Raymond Nien-Chen Kuo; Chih-Kuan Lai; Shih-Tzu Tsai; Yue-Chune Lee
Journal:  BMJ Open       Date:  2015-05-07       Impact factor: 2.692

7.  Change of government's subsidization policy improves smoking cessation services: a cross-sectional study from the perspectives of physicians.

Authors:  Tai-Yin Wu; Ling-Yu Hung; Wei-Chu Chie; Tai-Yuan Chiu; Fei-Ran Guo
Journal:  BMC Public Health       Date:  2016-05-17       Impact factor: 3.295

8.  Factors Correlated with Success Rate of Outpatient Smoking Cessation Services in Taiwan.

Authors:  Wei-Hsin Huang; Hsin-Yin Hsu; Betty Chia-Chen Chang; Fong-Ching Chang
Journal:  Int J Environ Res Public Health       Date:  2018-06-10       Impact factor: 3.390

9.  A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.

Authors:  Dan Xiao; Mitchell Kotler; Jian Kang; Chen Wang
Journal:  J Addict Med       Date:  2020 Jan/Feb       Impact factor: 4.647

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.